In the media: A Conversation with Atlas Antibodies CEO Ingela Hofverberg

In a recent interview with Stockholm Science City Foundation, Atlas Antibodies CEO Ingela Hofverberg reflects on a year marked by growth, innovation, and a strategic move to the heart of Sweden’s most vibrant life science district — Hagastaden.

Hagastaden is a purpose-built innovation district in central Stockholm, designed to bring together leading academic institutions, hospitals, startups, and global companies in life science, biotech, and healthtech. It is home to centers of excellence such as Karolinska Institutet, Karolinska University Hospital, SciLifeLab, and the Royal Institute of Technology. Hagastaden has long been the base for the Human Protein Atlas — the scientific foundation of Atlas Antibodies. With the company’s headquarters now also located in the district, its close connection to the life science community has been further reinforced.

Atlas Antibodies CEO Ingela Hofverberg

The Stockholm Science City Foundation is a non-profit organization that promotes the development of Hagastaden as a world-leading hub for life science and innovation, strengthening collaboration between academia, healthcare, and industry.

From welcoming international partners at the new headquarters in Forskaren, to advancing groundbreaking technologies like MolBoolean, Ingela shares insights into the company’s journey, its strong scientific roots, and the importance of staying closely connected to the research community it serves.

Read the whole interview on Stockholm Science City Foundation.